Array 10-Q2014 Q1 Quarterly report

Filed: 1 Nov 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accuracy, advisory, affirmative, Alpine, anniversary, asset, asthma, behalf, bill, billed, bortezomib, carfilzomib, chose, close, commencement, commencing, committed, committee, component, concept, contract, convenience, coupon, covenant, curve, customary, daily, deducting, demonstrated, devoted, disproportionate, document, dollar, entity, equivalent, established, failure, Fargo, field, firm, found, frame, FTE, hiring, impairment, implemented, incremental, indenture, industry, insolvency, instrument, invented, issuer, JDC, jointly, JRC, kinesin, KSP, led, length, LIBOR, life, LLC, Loxo, MDS, mechanism, medical, merger, MM, monetary, monitor, monotherapy, mutation, objective, occurrence, oncogenic, Oncothyreon, oral, organization, Overview, paclitaxel, pathway, practical, predetermined, Prime, profit, proportion, protein, purpose, redeem, redeemed, redemption, renewal, representing, repurchase, residual, rest, restricted, restructuring, retain, revert, salary, save, seek, seeking, sensitivity, settled, Settlement, shifting, site, solid, spindle, standby, strategy, sublicense, sum, supplemental, supply, therapeutic, tightly, traded, trading, trustee, uncertainty, unsecured, variety, Velcade, venture, volatility, workforce, yield

Removed: activator, affecting, AG, AKT, amendment, AMG, applied, arising, assumption, ASU, attribute, award, beginning, built, Certificate, collaborator, colorectal, complex, conclude, condensed, continually, danoprevir, decision, Designation, detail, effected, EGFR, embedded, employee, ESPP, estate, execute, execution, exercised, existence, expansion, expire, extinguishment, forward, gastric, generated, glucokinase, grant, Holding, Incentive, individual, inherently, inseparable, insurance, InterMune, internally, lapsed, leadership, lease, longer, measured, methodology, modification, month, moving, November, original, outsourced, positively, prepaid, prosecute, protease, put, range, real, recording, recruit, Restated, Roche, satisfy, securing, sharing, shorter, structure, subjective, substitute, suspended, Topic, unrecognized, unvested, vesting, waiving, withholding, worked

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Array similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report of Array BioPharma Inc. (the “Registrant”) on Form 10-Q for the three months ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:


(a)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.



Date:	November 1, 2013	/s/ RON SQUARER
		Ron Squarer
		Chief Executive Officer


		/s/ R. MICHAEL CARRUTHERS
		R. Michael Carruthers
		Chief Financial Officer
		(Principal Financial and Accounting Officer)